- About CEED3
- Diabetes Information
- Diabetes Information
- Diabetes information - sites in Partner languages
- What is Monogenic Diabetes?
- Maturity-Onset Diabetes of the Young (MODY)
- Making a diagnosis of Monogenic Diabetes
- Monogenic Diabetes in Children - ISPAD Guidelines
- Neonatal Diabetes (Kir6.2)
- Renal Cysts and Diabetes (HNF1B)
- Other Types of Monogenic Diabetes
- Best Practice Guidelines
- Genetic Testing
- News & Events
- Research & Publications
- Links
- Contact Us
Objectives of CEED3
![]() |
Develop an enhanced European framework for research related to the development of diabetes diagnostic tools, bringing together the best researchers, the best samples and data sets for discovery and validation and the best development platforms for clinical tools and ensures widespread dissemination |
![]() |
Identify potential genetic and non-genetic biomarkers that can be used to differentiate between subtypes of diabetes |
![]() |
Develop a clinical tool to aid the diagnosis of monogenic diabetes |
![]() |
Identify and validate genetic and non-genetic biomarkers that can be used to identify individuals with early beta-cell dysfunction and use these to develop diagnostic tools for use in clinics |
![]() |
Identify and validate genetic and non-genetic biomarkers that can be used in early identification of patients with type 2 and monogenic diabetes at increased risk of developing chronic diabetic vascular complications and use these to develop diagnostic tools for use in clinics |
![]() |
Disseminate knowledge and provide training on diabetes differential diagnosis and CEED3 results to all potentially interested patient, professional and societal groups |